Madhavi Sahadevan | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Madhavi Sahadevan
Thiru Vi Ka Government Arts College

Madhavi Sahadevan
Affiliation Thiru Vi Ka Government Arts College
Country India
Scopus ID 58563556500
Documents 4
Citations 8
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards

Madhavi Sahadevan is a researcher affiliated with Thiru Vi Ka Government Arts College, India, whose scholarly work falls within pharmacology, toxicology and pharmaceutical science. Her publication record is indexed in Scopus under author identifier 58563556500 [1]. She is presented here in connection with the Women Researcher Award at the International Academic Achievements & Awards event [2].

Abstract

This article presents a neutral overview of the scholarly profile of Madhavi Sahadevan, a researcher at Thiru Vi Ka Government Arts College working in pharmacology, toxicology and pharmaceutical science. According to Scopus, her profile lists four documents, eight citations and an h-index of two [1]. The article summarizes her research profile, contributions, bibliometric standing and relevance to the Women Researcher Award [2].

Keywords

Women researcher; pharmacology; toxicology; pharmaceutical science; Scopus; research recognition; academic achievement.

Introduction

Academic recognition programs seek to acknowledge researchers whose work contributes to scientific knowledge and to the visibility of women in research. The Women Researcher Award, presented within the International Academic Achievements & Awards event, is intended to highlight such contributions across disciplines [2]. Madhavi Sahadevan is associated with Thiru Vi Ka Government Arts College in India, a public institution of higher education. Her research activity is documented through the Scopus database, which provides a verifiable record of indexed output [1].

Research Profile

Madhavi Sahadevan’s indexed work is classified under pharmacology, toxicology and pharmaceutical science, a field concerned with the actions of drugs, the safety of chemical substances and the development of therapeutic formulations. Her Scopus record is identified by author ID 58563556500 and currently lists four documents [1].

  • Affiliation: Thiru Vi Ka Government Arts College, India
  • Primary subject area: Pharmacology, Toxicology and Pharmaceutical Science
  • Scopus identifier: 58563556500

Research Contributions

The research contributions of Madhavi Sahadevan are reflected in peer-reviewed publications indexed by Scopus. Work in pharmacology and pharmaceutical science typically advances understanding of bioactive compounds, their mechanisms and their safety profiles. Her publications add to this body of literature and are accessible through the DOI system, which allows readers to consult the original articles directly [3]. Readers are encouraged to consult the primary publications for specific methods and findings [1].

Publications

Scopus lists four documents attributed to Madhavi Sahadevan [1]. The complete and current bibliography, including titles, journals and publication years, is available through her Scopus author profile. Individual articles can be located and cited through their DOIs [3].

Research Impact

Bibliometric indicators offer a limited but useful view of scholarly reach. As recorded in Scopus, Madhavi Sahadevan’s work has received eight citations, and her h-index is two [1]. These figures indicate an early-career or developing research record, and they may change as new publications appear and existing work is cited.

  • Documents: 4
  • Citations: 8
  • h-index: 2

Award Suitability

The Women Researcher Award recognizes women who contribute to research through indexed publications and scholarly engagement [2]. Madhavi Sahadevan’s verifiable Scopus record, her focus on pharmacology, toxicology and pharmaceutical science, and her affiliation with a government arts college provide a documented basis for consideration [1]. Final selection rests with the organizing committee and its stated criteria.

Conclusion

Madhavi Sahadevan is a researcher at Thiru Vi Ka Government Arts College whose indexed work in pharmacology, toxicology and pharmaceutical science is documented in Scopus. With four documents, eight citations and an h-index of two, her record reflects a growing contribution to the field [1]. Her association with the Women Researcher Award highlights the importance of recognizing women in research [2].

References

  1. Elsevier. (n.d.). Scopus author details: Madhavi Sahadevan, Author ID 58563556500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58563556500
  2. Quantum mechanical approaches and molecular docking studies of metal based anticancer drugs cis-Diammine glycolato platinum and Diaminocyclohexane oxalatoplatinum structures.
    https://www.sciencedirect.com/science/article/abs/pii/S1476927123001317
  3. Molecular Docking Studies of Platinum Metal-Based Anticancer Drugs Cis-Diamineglycolatoplatinum and its Derivatives Binding Affinity with Three Different Types of Cancer Cell.
    https://nanobioletters.com/wp-content/uploads/2024/09/LIANBS141.036.pdf
  4. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID, Inc.
    https://orcid.org/
  5. Elsevier. (n.d.). Scopus: Abstract and citation database. Elsevier B.V.
    https://www.scopus.com/

Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311